au-007
aulos biosciences
['au007 ', 'aulos bioscience', 'aulos ']
we're excited to share the study design of our phase 1/2 trial of #au007 at #asco2022. with an moa that sets it apart from other #il2 therapeutics in development, it addresses the negative feedback loop &amp; could potentially subdue immune suppression &amp; prevent toxic side effects.
We’re revolutionizing #cancercare through #IL2 therapeutics designed to direct the #immunesystem to destroy cancers. #ImmunoOncology #Oncology